Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepato Cellular Carcinoma (HCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableLooking for participantsNCT06990659
What this trial is testing

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Who this might be right for
Hepato Cellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma
University Hospital, Angers 206
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07560566
What this trial is testing

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hand Foot Skin Syndrome
National Taiwan University Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT07276100
What this trial is testing

Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab

Who this might be right for
Hepato Cellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 15
Not applicableUnknownNCT05494853
What this trial is testing

Novel Biomarker Assay for Biomarker Assay for HCC Detection

Who this might be right for
Hepato-cellular Carcinoma
Genetron Health 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07734766
What this trial is testing

Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery

Who this might be right for
Hepato Cellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 45
Not applicableNot Yet RecruitingNCT07716345
What this trial is testing

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Ended earlyNCT06848556
What this trial is testing

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Zhejiang Raygene Pharmaceuticals Co., Ltd 16
Not applicableLooking for participantsNCT07142213
What this trial is testing

Effect and Mechanism of ALPPS Operation on Liver Regeneration

Who this might be right for
Hepato Cellular Carcinoma (HCC)Hepatobiliary CancersLiver Cancer+1 more
Haitao Zhao, MD 50
Large-scale testing (Phase 3)Looking for participantsNCT07267806
What this trial is testing

Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC

Who this might be right for
Hepato Cellular Carcinoma (HCC)Chemotherapy Effect
Linhui Peng 326
Testing effectiveness (Phase 2)WithdrawnNCT06608940
What this trial is testing

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Case Comprehensive Cancer Center